Printer Friendly

CURATIVE TECHNOLOGIES ANNOUNCES FIRST QUARTER RESULTS

 CURATIVE TECHNOLOGIES ANNOUNCES FIRST QUARTER RESULTS
 EAST SETAUKET, N.Y., May 1 /PRNewswire/ -- Curative Technologies,


Inc. (NASDAQ: CURE) ("CTI"), today announced results of operations for the first quarter ended March 31, 1992.
 Total revenues for the first quarter of 1992 were $6,258,000, up 67 percent from $3,744,000 reported for the first quarter of 1991. This represents record quarterly revenues for Curative Technologies. Net loss for the first quarter 1992 was $285,000, or $(0.03) per share, compared to a net loss of $657,000, or $(0.20) per share, for the first quarter 1991.
 Commenting on the quarter, Russell B. Whitman, chairman, president and chief executive officer, stated, "CTI has achieved strong growth and currently has 37 Wound Care Centers(R) operating and contracts or letters of intent executed to open an additional eight centers. Discussions with the Food and Drug Administration continue and the company is optimistic that clinical trials for CT-102 (homologous PDWHF) for diabetic ulcers will commence in the near term. European clinical trials are also progressing. CTI and its hospital partners have been involved in numerous discussions in recent weeks with third party insurers, including Medicare, concerning the reimbursement and coverage and Procuren(R). This is due to a number of recent and inconsistent determinations by Medicare intermediaries and other insurers as to the eligibility of Procuren for reimbursement and coverage purposes. The Health Care Financing Administration, the agency that administers the Medicare Program nationally, is reviewing this matter and may decide to clarify its position on this issue."
 Curative Technologies, Inc., is a biopharmaceutical company engaged in the research, development, production and marketing of therapeutic products utilizing naturally occurring human growth factors. The company's first product, Procuren, is a topical therapeutic which promotes wound healing and is produced from a patient's own blood. Procuren is sold through Wound Care Centers, which are cooperative ventures with selected hospitals.
 CURATIVE TECHNOLOGIES, INC., AND SUBSIDIARY
 Selected Financial Information
 Condensed Consolidated Statement of Operations
 (Dollars in thousands except per share data; unaudited)
 Three months ended March 31 1992 1991
 Revenue $6,258 $3,744
 Cost and expenses:
 Cost of product sales 1,138 720
 Research and development 1,351 1,073
 Marketing, general & administrative 4,356 2,642
 Total costs and expenses 6,845 4,435
 Loss from operations (587) (691)
 Interest income 266 34
 Net loss before minority interest (321) (657)
 Minority interest in net loss
 of consolidated subsidiary 36 --
 Net loss $ (285) $ (657)
 Net loss per common share $(.03) $(.20)
 Weighted average common shares outstg. 9,875 6,355
 Condensed Consolidated Balance Sheet
 (Dollars in thousands; unaudited)
 3/31/92 12/31/91
 Assets
 Cash and cash equivalents $15,170 $18,919
 Marketable securities 7,034 5,963
 Other current assets 6,672 5,307
 Property and equipment (net) 1,875 1,515
 Other assets 587 755
 Total 31,338 32,459
 Liabilities and Stockholders' Equity
 Current liabilities 5,179 5,779
 Long-term debt 254 343
 Other liabilities 1,182 1,280
 Stockholders' equity 24,723 25,057
 Total $31,338 $32,459
 -0- 5/1/92
 /CONTACT: John C. Prior, chief financial officer of Curative Technologies, 516-689-7000/
 (CURE) CO: Curative Technologies, Inc. ST: New York IN: MTC SU: ERN


GK-OS -- NY014 -- 5352 05/01/92 09:48 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 1, 1992
Words:547
Previous Article:DETROIT EDISON BRINGS MARYSVILLE POWER PLANT ON LINE
Next Article:'WHEELS OF MICHIGAN' OPENS TODAY


Related Articles
CURATIVE TECHNOLOGIES ANNOUNCES FOURTH QUARTER AND YEAR END RESULTS
CURATIVE TECHNOLOGIES ANNOUNCES FOURTH QUARTER AND YEAR END RESULTS
CURATIVE TECHNOLOGIES ANNOUNCES SECOND QUARTER RESULTS
CURATIVE TECHNOLOGIES INC. ANNOUNCES FIRST QUARTER RESULTS
CURATIVE TECHNOLOGIES, INC. ANNOUNCES SECOND QUARTER RESULTS
CURATIVE TECHNOLOGIES INC. ANNOUNCES FIRST QUARTER RESULTS
/C O R R E C T I O N -- CURATIVE TECHNOLOGIES/
CURATIVE TECHNOLOGIES, INC. ANNOUNCES FIRST QUARTER RESULTS
CURATIVE TECHNOLOGIES, INC. ANNOUNCES SECOND QUARTER RESULTS

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters